Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.

Life sciences

Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM.
PMID: 34968466
Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27.

Diabetic nephropathy (DN) is a serious complication of diabetes and can lead to renal failure. Telmisartan (TEL) is an approved angiotensin II type 1 receptor blocker for the treatment of hypertension and possesses nephroprotective efficacy. The study investigated the...

Cite
Antar SA, Abdo W, Taha RS, et al. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021;291:120260doi: 10.1016/j.lfs.2021.120260.
Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., Abdel Monsef, A. S., Abdel Hamid, A. M., Kamel, E. M., Ahmeda, A. F., & Mahmoud, A. M. (2021). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life sciences, 291120260. https://doi.org/10.1016/j.lfs.2021.120260
Antar, Samar A, et al. "Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats." Life sciences vol. 291 (2021): 120260. doi: https://doi.org/10.1016/j.lfs.2021.120260
Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27. PMID: 34968466.
Copy Download .nbib Format: NLM
Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.

Life sciences

Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM.
PMID: 34968466
Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27.

Diabetic nephropathy (DN) is a serious complication of diabetes and can lead to renal failure. Telmisartan (TEL) is an approved angiotensin II type 1 receptor blocker for the treatment of hypertension and possesses nephroprotective efficacy. The study investigated the...

Cite
Antar SA, Abdo W, Taha RS, et al. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021;291:120260doi: 10.1016/j.lfs.2021.120260.
Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., Abdel Monsef, A. S., Abdel Hamid, A. M., Kamel, E. M., Ahmeda, A. F., & Mahmoud, A. M. (2021). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life sciences, 291120260. https://doi.org/10.1016/j.lfs.2021.120260
Antar, Samar A, et al. "Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats." Life sciences vol. 291 (2021): 120260. doi: https://doi.org/10.1016/j.lfs.2021.120260
Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27. PMID: 34968466.
Copy Download .nbib Format: NLM
Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.

Life sciences

Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM.
PMID: 34968466
Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27.

Diabetic nephropathy (DN) is a serious complication of diabetes and can lead to renal failure. Telmisartan (TEL) is an approved angiotensin II type 1 receptor blocker for the treatment of hypertension and possesses nephroprotective efficacy. The study investigated the...

Cite
Antar SA, Abdo W, Taha RS, et al. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021;291:120260doi: 10.1016/j.lfs.2021.120260.
Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., Abdel Monsef, A. S., Abdel Hamid, A. M., Kamel, E. M., Ahmeda, A. F., & Mahmoud, A. M. (2021). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life sciences, 291120260. https://doi.org/10.1016/j.lfs.2021.120260
Antar, Samar A, et al. "Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats." Life sciences vol. 291 (2021): 120260. doi: https://doi.org/10.1016/j.lfs.2021.120260
Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27. PMID: 34968466.
Copy Download .nbib Format: NLM
Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.

Life sciences

Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM.
PMID: 34968466
Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27.

Diabetic nephropathy (DN) is a serious complication of diabetes and can lead to renal failure. Telmisartan (TEL) is an approved angiotensin II type 1 receptor blocker for the treatment of hypertension and possesses nephroprotective efficacy. The study investigated the...

Cite
Antar SA, Abdo W, Taha RS, et al. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021;291:120260doi: 10.1016/j.lfs.2021.120260.
Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., Abdel Monsef, A. S., Abdel Hamid, A. M., Kamel, E. M., Ahmeda, A. F., & Mahmoud, A. M. (2021). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life sciences, 291120260. https://doi.org/10.1016/j.lfs.2021.120260
Antar, Samar A, et al. "Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats." Life sciences vol. 291 (2021): 120260. doi: https://doi.org/10.1016/j.lfs.2021.120260
Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27. PMID: 34968466.
Copy Download .nbib Format: NLM
Omega-3 Self-Nanoemulsion Role in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats.

Pharmaceutics

Ahmed OAA, Fahmy UA, Bakhaidar R, El-Moselhy MA, Okbazghi SZ, Ahmed AF, Hammad ASA, Alhakamy NA.
PMID: 32045979
Pharmaceutics. 2020 Feb 07;12(2). doi: 10.3390/pharmaceutics12020140.

Peptic ulcer disease is an injury of the alimentary tract that leads to a mucosal defect reaching the submucosa. This study aimed to formulate and optimize omega-3 oil as a self-nanoemulsifying drug delivery system (SNEDDS) to achieve oil dispersion...

Cite
Ahmed OAA, Fahmy UA, Bakhaidar R, et al. Omega-3 Self-Nanoemulsion Role in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats. Pharmaceutics. 2020;12(2)doi: 10.3390/pharmaceutics12020140.
Ahmed, O. A. A., Fahmy, U. A., Bakhaidar, R., El-Moselhy, M. A., Okbazghi, S. Z., Ahmed, A. F., Hammad, A. S. A., & Alhakamy, N. A. (2020). Omega-3 Self-Nanoemulsion Role in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats. Pharmaceutics, 12(2), . https://doi.org/10.3390/pharmaceutics12020140
Ahmed, Osama A A, et al. "Omega-3 Self-Nanoemulsion Role in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats." Pharmaceutics vol. 12,2 (2020). doi: https://doi.org/10.3390/pharmaceutics12020140
Ahmed OAA, Fahmy UA, Bakhaidar R, El-Moselhy MA, Okbazghi SZ, Ahmed AF, Hammad ASA, Alhakamy NA. Omega-3 Self-Nanoemulsion Role in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats. Pharmaceutics. 2020 Feb 07;12(2). doi: 10.3390/pharmaceutics12020140. PMID: 32045979; PMCID: PMC7076357.
Copy Download .nbib Format: NLM
Fluorescence Spectrometric Determination of Drugs Containing α-Methylene Sulfone/Sulfonamide Functional Groups Using N-Methylnicotinamide Chloride as a Fluorogenic Agent.

International journal of analytical chemistry

Elokely KM, Eldawy MA, Elkersh MA, El-Moselhy TF.
PMID: 21647288
Int J Anal Chem. 2011;2011:840178. doi: 10.1155/2011/840178. Epub 2011 May 16.

A simple spectrofluorometric method has been developed, adapted, and validated for the quantitative estimation of drugs containing α-methylene sulfone/sulfonamide functional groups using N(1)-methylnicotinamide chloride (NMNCl) as fluorogenic agent. The proposed method has been applied successfully to the determination of...

Cite
Elokely KM, Eldawy MA, Elkersh MA, et al. Fluorescence Spectrometric Determination of Drugs Containing α-Methylene Sulfone/Sulfonamide Functional Groups Using N-Methylnicotinamide Chloride as a Fluorogenic Agent. Int J Anal Chem. 2011;2011:840178doi: 10.1155/2011/840178.
Elokely, K. M., Eldawy, M. A., Elkersh, M. A., & El-Moselhy, T. F. (2011). Fluorescence Spectrometric Determination of Drugs Containing α-Methylene Sulfone/Sulfonamide Functional Groups Using N-Methylnicotinamide Chloride as a Fluorogenic Agent. International journal of analytical chemistry, 2011840178. https://doi.org/10.1155/2011/840178
Elokely, Khaled M, et al. "Fluorescence Spectrometric Determination of Drugs Containing α-Methylene Sulfone/Sulfonamide Functional Groups Using N-Methylnicotinamide Chloride as a Fluorogenic Agent." International journal of analytical chemistry vol. 2011 (2011): 840178. doi: https://doi.org/10.1155/2011/840178
Elokely KM, Eldawy MA, Elkersh MA, El-Moselhy TF. Fluorescence Spectrometric Determination of Drugs Containing α-Methylene Sulfone/Sulfonamide Functional Groups Using N-Methylnicotinamide Chloride as a Fluorogenic Agent. Int J Anal Chem. 2011;2011:840178. doi: 10.1155/2011/840178. Epub 2011 May 16. PMID: 21647288; PMCID: PMC3103861.
Copy Download .nbib Format: NLM
Hepatocyte Lysosomal Membrane Stabilization by Olive Leaves against Chemically Induced Hepatocellular Neoplasia in Rats.

International journal of hepatology

Abdel-Hamid NM, El-Moselhy MA, El-Baz A.
PMID: 21994869
Int J Hepatol. 2011;2011:736581. doi: 10.4061/2011/736581. Epub 2010 Dec 05.

Extensive efforts are exerted looking for safe and effective chemotherapy for hepatocellular carcinoma (HCC). Specific and sensitive early biomarkers for HCC still in query. Present work to study proteolytic activity and lysosomal membrane integrity by hepatocarcinogen, trichloroacetic acid (TCA),...

Cite
Abdel-Hamid NM, El-Moselhy MA, El-Baz A. Hepatocyte Lysosomal Membrane Stabilization by Olive Leaves against Chemically Induced Hepatocellular Neoplasia in Rats. Int J Hepatol. 2010;2011:736581doi: 10.4061/2011/736581.
Abdel-Hamid, N. M., El-Moselhy, M. A., & El-Baz, A. (2011). Hepatocyte Lysosomal Membrane Stabilization by Olive Leaves against Chemically Induced Hepatocellular Neoplasia in Rats. International journal of hepatology, 2011736581. https://doi.org/10.4061/2011/736581
Abdel-Hamid, N M, et al. "Hepatocyte Lysosomal Membrane Stabilization by Olive Leaves against Chemically Induced Hepatocellular Neoplasia in Rats." International journal of hepatology vol. 2011 (2011): 736581. doi: https://doi.org/10.4061/2011/736581
Abdel-Hamid NM, El-Moselhy MA, El-Baz A. Hepatocyte Lysosomal Membrane Stabilization by Olive Leaves against Chemically Induced Hepatocellular Neoplasia in Rats. Int J Hepatol. 2011;2011:736581. doi: 10.4061/2011/736581. Epub 2010 Dec 05. PMID: 21994869; PMCID: PMC3170841.
Copy Download .nbib Format: NLM
Optimized Self-Nanoemulsifying Delivery System Based on Plant-Derived Oil Augments Alpha-Lipoic Acid Protective Effects Against Experimentally Induced Gastric Lesions.

Dose-response : a publication of International Hormesis Society

Badr-Eldin SM, Fahmy UA, Aldawsari HM, Ahmed OAA, Alhakamy NA, Okbazghi SZ, El-Moselhy MA, Alghaith AF, Anter A, Matouk AI, Mahdi WA, Alshehri S, Bakhaidar R.
PMID: 33867893
Dose Response. 2021 Mar 30;19(1):15593258211001259. doi: 10.1177/15593258211001259. eCollection 2021.

Peptic ulcer disease is an injury of the alimentary tract that leads to a mucosal defect reaching the submucosa. Alpha-lipoic acid (ALA), a natural potent antioxidant, has been known as a gastroprotective drug yet its low bioavailability may restrict...

Cite
Badr-Eldin SM, Fahmy UA, Aldawsari HM, et al. Optimized Self-Nanoemulsifying Delivery System Based on Plant-Derived Oil Augments Alpha-Lipoic Acid Protective Effects Against Experimentally Induced Gastric Lesions. Dose Response. 2021;19(1):15593258211001259doi: 10.1177/15593258211001259.
Badr-Eldin, S. M., Fahmy, U. A., Aldawsari, H. M., Ahmed, O. A. A., Alhakamy, N. A., Okbazghi, S. Z., El-Moselhy, M. A., Alghaith, A. F., Anter, A., Matouk, A. I., Mahdi, W. A., Alshehri, S., & Bakhaidar, R. (2021). Optimized Self-Nanoemulsifying Delivery System Based on Plant-Derived Oil Augments Alpha-Lipoic Acid Protective Effects Against Experimentally Induced Gastric Lesions. Dose-response : a publication of International Hormesis Society, 19(1), 15593258211001259. https://doi.org/10.1177/15593258211001259
Badr-Eldin, Shaimaa M, et al. "Optimized Self-Nanoemulsifying Delivery System Based on Plant-Derived Oil Augments Alpha-Lipoic Acid Protective Effects Against Experimentally Induced Gastric Lesions." Dose-response : a publication of International Hormesis Society vol. 19,1 (2021): 15593258211001259. doi: https://doi.org/10.1177/15593258211001259
Badr-Eldin SM, Fahmy UA, Aldawsari HM, Ahmed OAA, Alhakamy NA, Okbazghi SZ, El-Moselhy MA, Alghaith AF, Anter A, Matouk AI, Mahdi WA, Alshehri S, Bakhaidar R. Optimized Self-Nanoemulsifying Delivery System Based on Plant-Derived Oil Augments Alpha-Lipoic Acid Protective Effects Against Experimentally Induced Gastric Lesions. Dose Response. 2021 Mar 30;19(1):15593258211001259. doi: 10.1177/15593258211001259. eCollection 2021. PMID: 33867893; PMCID: PMC8020240.
Copy Download .nbib Format: NLM
Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.

Life sciences

Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM.
PMID: 34968466
Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27.

Diabetic nephropathy (DN) is a serious complication of diabetes and can lead to renal failure. Telmisartan (TEL) is an approved angiotensin II type 1 receptor blocker for the treatment of hypertension and possesses nephroprotective efficacy. The study investigated the...

Cite
Antar SA, Abdo W, Taha RS, et al. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021;291:120260doi: 10.1016/j.lfs.2021.120260.
Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., Abdel Monsef, A. S., Abdel Hamid, A. M., Kamel, E. M., Ahmeda, A. F., & Mahmoud, A. M. (2021). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life sciences, 291120260. https://doi.org/10.1016/j.lfs.2021.120260
Antar, Samar A, et al. "Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats." Life sciences vol. 291 (2021): 120260. doi: https://doi.org/10.1016/j.lfs.2021.120260
Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27. PMID: 34968466.
Copy Download .nbib Format: NLM
Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.

Life sciences

Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM.
PMID: 34968466
Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27.

Diabetic nephropathy (DN) is a serious complication of diabetes and can lead to renal failure. Telmisartan (TEL) is an approved angiotensin II type 1 receptor blocker for the treatment of hypertension and possesses nephroprotective efficacy. The study investigated the...

Cite
Antar SA, Abdo W, Taha RS, et al. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021;291:120260doi: 10.1016/j.lfs.2021.120260.
Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., Abdel Monsef, A. S., Abdel Hamid, A. M., Kamel, E. M., Ahmeda, A. F., & Mahmoud, A. M. (2021). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life sciences, 291120260. https://doi.org/10.1016/j.lfs.2021.120260
Antar, Samar A, et al. "Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats." Life sciences vol. 291 (2021): 120260. doi: https://doi.org/10.1016/j.lfs.2021.120260
Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdel Monsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021 Dec 27;291:120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27. PMID: 34968466.
Copy Download .nbib Format: NLM
Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.

Life sciences

Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdmonsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM.
PMID: 34968466
Life Sci. 2021 Dec 27;120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27.

Diabetic nephropathy (DN) is a serious complication of diabetes and can lead to renal failure. Telmisartan (TEL) is an approved angiotensin II type 1 receptor blocker for the treatment of hypertension and possesses nephroprotective efficacy. The study investigated the...

Cite
Antar SA, Abdo W, Taha RS, et al. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021;120260doi: 10.1016/j.lfs.2021.120260.
Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., Abdmonsef, A. S., Abdel Hamid, A. M., Kamel, E. M., Ahmeda, A. F., & Mahmoud, A. M. (2021). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life sciences, 120260. https://doi.org/10.1016/j.lfs.2021.120260
Antar, Samar A, et al. "Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats." Life sciences vol. (2021): 120260. doi: https://doi.org/10.1016/j.lfs.2021.120260
Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, Abdmonsef AS, Abdel Hamid AM, Kamel EM, Ahmeda AF, Mahmoud AM. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sci. 2021 Dec 27;120260. doi: 10.1016/j.lfs.2021.120260. Epub 2021 Dec 27. PMID: 34968466.
Copy Download .nbib Format: NLM
Synthesis and characterization of hybrid iron oxide silicates for selective removal of arsenic oxyanions from contaminated water.

Journal of colloid and interface science

El-Moselhy MM, Ates A, Çelebi A.
PMID: 27842266
J Colloid Interface Sci. 2017 Feb 15;488:335-347. doi: 10.1016/j.jcis.2016.11.003. Epub 2016 Nov 05.

A series of hybrid silicates containing iron oxides was synthesized by adding various amounts of iron into silica on the basis of using post precipitation mechanism from aqueous solutions in order to form hydrated iron oxide species (HFO). The...

Cite
El-Moselhy MM, Ates A, Çelebi A. Synthesis and characterization of hybrid iron oxide silicates for selective removal of arsenic oxyanions from contaminated water. J Colloid Interface Sci. 2016;488:335-347doi: 10.1016/j.jcis.2016.11.003.
El-Moselhy, M. M., Ates, A., & Çelebi, A. (2017). Synthesis and characterization of hybrid iron oxide silicates for selective removal of arsenic oxyanions from contaminated water. Journal of colloid and interface science, 488335-347. https://doi.org/10.1016/j.jcis.2016.11.003
El-Moselhy, Medhat Mohamed, et al. "Synthesis and characterization of hybrid iron oxide silicates for selective removal of arsenic oxyanions from contaminated water." Journal of colloid and interface science vol. 488 (2017): 335-347. doi: https://doi.org/10.1016/j.jcis.2016.11.003
El-Moselhy MM, Ates A, Çelebi A. Synthesis and characterization of hybrid iron oxide silicates for selective removal of arsenic oxyanions from contaminated water. J Colloid Interface Sci. 2017 Feb 15;488:335-347. doi: 10.1016/j.jcis.2016.11.003. Epub 2016 Nov 05. PMID: 27842266.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries